MADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottle

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2c9542d751cec4fe
Product Name: MADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottle
Artg Id: 13744
Artg Name: MADOPAR 62.5 levodopa 50 mg and benserazide 12.5 mg capsule bottle
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 1991-08-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-CMI-01768-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-02391-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2c9542d751cec4fe

Type

Standard